thioredoxin-1 (TRX1) in a redox-dependent manner. Formation of the TXNIP-TRX1 complex relieves inhibition of the apoptosis signal-regulating kinase 1-c-Jun N-terminal kinase-vascular cell adhesion molecule-1 pathway. Because TXNIP is an ␣-arrestin with numerous protein-protein interacting domains, we hypothesized that TXNIP-TRX1 trafficking should alter function of EC exposed to reactive oxygen species (ROS). Methods and Results-In response to physiological levels of ROS (10 ng/mL tumor necrosis factor-␣ and 30 mol/L H 2 O 2 ), TXNIP-TRX1 translocated to the plasma membrane in human umbilical vein EC, with a peak at 30 minutes, as measured by immunofluorescence colocalization with vascular endothelial-cadherin, cell fractionation, and membrane sheet assay. TXNIP-mediated translocation of TRX1 to the membrane required TXNIP and TRX1 binding, as evidenced by inability of the ROS-insensitive TXNIP-Cys247Ser mutant to promote membrane localization. Vascular endothelial growth factor signaling required TXNIP, as shown by significant decreases in plasma membrane tyrosine phosphorylation and EC migration after TRX1 knockdown. Furthermore, TXNIP knockdown increased human umbilical vein EC apoptosis induced by tumor necrosis factor. Rescue with TXNIP-wild-type but not TXNIP-Cys247Ser prevented cell death.
T hioredoxin-1 (TRX1), a highly conserved and ubiquitous oxidoreductase, is responsible for restoring oxidized proteins to their reduced form. 1 In addition to its role as a scavenger of reactive oxygen species (ROS), TRX1 regulates transcription and cell signaling, resulting in the modulation of cell growth and survival. 2 To this end, TRX1 exerts a protective effect by controlling signal transduction via the regulation of kinase and phosphatase action. [3] [4] [5] The activity of TRX1 is regulated by TRX1-interacting protein (TXNIP), which exhibits homology with ␤-arrestin proteins. 6, 7 This interaction requires cysteine 247 of TXNIP and involves the formation of a mixed disulfide with reduced TRX1. 8 The nuclear accumulation of TRX1 in cardiomyocytes was recently shown to protect against cardiac hypertrophy and was found to require the action of TXNIP as a scaffold. 9 In addition, changes in the localization of TRX1 have been shown necessary for the activation of the prosurvival kinase Akt in response to ischemic preconditioning of the heart. 10 Inflammation induced by cytokines, such as tumor necrosis factor ␣ (TNF-␣), requires the ROS-mediated dissociation of TRX1 from apoptosis signal-regulating kinase 1 (ASK1). 11 The release of TRX1 from ASK1 mediates ASK1 activation and endothelial cell (EC) apoptosis in response to TNF-␣. 12 In addition, overexpression of TXNIP was shown to disrupt TRX1-ASK1 binding and mediate an increase in prooxidant cell death. 7 It is important to note that work in our laboratory has previously focused on the regulation of signaling and inflammation by changes in the interaction of TXNIP and TRX1 after exposure of EC to physiological steady laminar flow. 13 TXNIP expression was very low in steady flow, whereas in disturbed flow, TXNIP significantly increased. Furthermore, the expression of TXNIP was associated with the inhibition of TRX1 and promotion of proinflammatory signals, such as vascular cell adhesion molecule-1, in response to TNF-␣. These results suggest that TXNIP-TRX1 interaction is highly relevant to the pathogenic processes involved in the promotion of oxidative stress and chronic inflammation. Because the activity of TRX1 is regulated by its spatial localization and because TXNIP likely is a scaffold based on sequence homology to ␣-arrestins, we hypothesized that TXNIP might regulate TRX1 localization and EC function. Using physiological levels of ROS (10 ng/mL TNF-␣ and 30 mol/L H 2 O 2 ), we show that TXNIP acts as a scaffold for TRX1, promoting translocation to the plasma membrane. Furthermore, TXNIP controls ROS-mediated changes in vascular endothelial growth factor receptor-2 (VEGFR2) signaling, as evidenced by EC migration and survival.
Materials and Methods

Cell Culture
Human umbilical vein EC (HUVEC) were isolated from human umbilical veins and seeded onto gelatin-coated 60-mm dishes maintained in Medium 200 (Cascade Biologics, Portland, OR) with lowserum growth supplement and 5% FBS as previously described. 14 Cells were used at passages 2 to 4. Fetal bovine aortic EC were purchased from Clontech and cultured in Medium 199 supplemented with 10% FetalClone III (Thermo Scientific, Logan UT), basal minimal essential media vitamins (Invitrogen, Carlsbad, CA), and amino acids (Invitrogen). Cells at passages 4 to 10 were used for experiments.
Plasma Membrane Protein Preparation
Plasma membrane proteins were isolated from EC according to the method previously described. 15
Immunoprecipitation and Western Blotting
HUVEC were washed twice in ice-cold PBS, and lysates were prepared. Immunoprecipitations were performed as described in Cavet, 2008. 16 Immune complex samples or protein samples from total cell lysates were separated by SDS-PAGE, transferred to a nitrocellulose membrane, and incubated with appropriate primary antibodies. After washing and incubation with secondary antibodies (LiCor Biosciences, Lincoln NE), immunoreactive proteins were visualized with the Odyssey LiCor Infrared Imaging System. Densitometry of blots was performed using ImageJ software (version 1.36b, National Institutes of Health). Primary antibodies included VDUP1 (TXNIP) (catalog no. 403700, Invitrogen), green fluorescent protein (GFP) (catalog no. 632460, Clontech), and VE-cadherin (catalog no. sc-9989, Santa Cruz Biotechnology).
Plasma Membrane Sheet Assay
Preparation of plasma membrane sheets and immunofluorescence were performed as described previously. 17 Briefly, images were obtained with an Olympus BX51 fluorescent microscope using Spot software (version 3.5.9 for MacOS, Diagnostic Instruments, Inc). Fluorescence intensity of immunostained plasma membrane sheets was multiplied by a constant applied equally to all parts of an entire image using the Adjust Levels tool of Photoshop CS3 (version 10.0) and quantified with ImageJ (version 1.36b).
EC Migration
For detection of cell migration, a wound healing assay was performed. 18 Fetal bovine aortic EC were grown to confluence in a 12-well plate and continuously cultured in serum-free medium for an additional 24 hours.
A longitudinal wound was made in the middle of the dish with a sterile scalpel. Cells were stimulated with vascular endothelial growth factor (VEGF) (20 ng/mL), 30 mol/L H 2 O 2 , or 10 ng/mL TNF-␣ for 16 hours, and cell migration was measured as percentage of recovered area using light microscopy and ImageJ (version 1.36b).
Terminal Deoxynucleotidyl Transferase dUTP Nick-End Labeling and Apoptosis Assays
Measurement of terminal deoxynucleotidyl transferase dUTP nick-end labeling fluorescence was performed according to the manufacturer's instructions (Roche Applied Science). For nuclear dye analysis, EC were fixed with paraformaldehyde, stained with Hoescht 33342, and examined under a fluorescent microscope. Cells exhibiting nuclear fragmentation or condensation were counted in 3 fields, and the percentage of apoptosis is represented relative to total cells counted.
Quantification of Membrane Protein Colocalization
Quantification of membrane-associated TXNIP was performed by first creating overlapping images between TXNIP and VE-cadherin and pseudocoloring the resulting yellow to blue (Supplemental Figure IA to ID, available online at http://atvb.ahajournals.org). These RGB images were then opened in the ImageJ software, and the individual blue channel image was created in black and white, inverted to enable counting of black pixels. Colocalized fluorescent signals were quantified by measuring pixel area (Supplemental Figure IE and IF and Supplemental Table I ).
Statistical Analysis
Group differences were analyzed using the standard Student t test. All values are expressed as meanϮSE. PϽ0.05 was considered statistically significant.
Results
TXNIP Translocation to the Plasma Membrane
To determine whether TXNIP acted as an arrestin-like scaffold at the membrane, we first characterized endogenous TXNIP location on treatment with H 2 O 2 as an exogenous source of ROS and TNF-␣, a physiological agonist that initiates signaling via the generation of intracellular ROS. 19, 20 Immunofluorescence analysis of endogenous protein showed that in growth-arrested HUVEC, TXNIP localized almost exclusively to the nucleus ( Figure 1A ), as reported by others. 21 The plasma membrane of these cells was delineated by staining for vascular endothelial (VE)-cadherin ( Figure  1B) , with the merge of these images showing little colocalization ( Figure 1C ). Stimulation with 30 mol/L H 2 O 2 for 30 minutes caused translocation of TXNIP to the cytosol and membrane ( Figure 1D ). After TNF-␣ stimulation, TXNIP also translocated to the membrane, as shown by colocalization with VE-cadherin ( Figure 1G to 1I). We also studied the time course for H 2 O 2 -and TNF-␣-mediated TXNIP translocation. The time course for H 2 O 2 was similar to that of TNF-␣ ( Figure 1A to 1I and Supplemental Figures II and V), although the magnitude was greater for TNF-␣.
Next, these results were confirmed by the use of the plasma membrane sheet assay, which specifically visualizes plasma membrane proteins. 17, 22, 23 Plasma membrane sheets prepared from unstimulated HUVEC exhibited minimal TXNIP immunofluorescence, suggesting that TXNIP was primarily cytoplasmic or nuclear (Figure 2A ). H 2 O 2 or TNF-␣ stimulation caused a dramatic increase in TXNIP association with the plasma membrane, which was maximal after 30 minutes ( Figure 2B and Supplemental Figure II) , similar to the immunofluorescence data in Figure 1 . Western analysis of plasma membrane sheets was performed to assess the purity of plasma membrane sheet proteins. Immunoblotting of platelet EC adhesion molecule-1 and lamin A/C (Supplemental Figure IIIA) , markers of the plasma and nuclear membrane, respectively, showed that there was minimal contamination by nuclear membrane proteins (Supplemental Figure  IIIB) . Importantly, H 2 O 2 stimulation did not change TXNIP total protein expression, as shown by Western blotting (Supplemental Figure IV) .
To provide further evidence for TXNIP translocation, we performed cell fractionation. Cell fractionation showed that under basal conditions, the majority of TXNIP was nuclear and translocated to the plasma membrane following stimulation with H 2 O 2 ( Figure 2C ) or TNF-␣ (Supplemental Figure V) .
TRX1 Translocation to the Plasma Membrane Has A Time Course Similar to TXNIP Translocation
Because TXNIP interacts with TRX1 under conditions of oxidative stress, we assessed whether TRX1 also translocated to the plasma membrane in response to 30 mol/L H 2 O 2 . Under control conditions, TRX1 was primarily cytoplasmic, and there was minimal TRX1 associated with the plasma membrane (Supplemental Figure VIA) . In response to H 2 O 2 , there was a dramatic increase in TRX1 associated with the plasma membrane, which, like TXNIP, was maximal at 30 minutes (*PϽ0.001 compared with tϭ0) (Supplemental Figure VIA) . To further confirm the translocation of TRX1 to the membrane, cytosol and membrane proteins isolated by cell fractionation were prepared from EC stimulated with H 2 O 2 for 30 minutes or maintained in serum-free medium. Western analysis indicated that under control conditions, TRX1 was localized to the cytoplasm and absent from the plasma membrane (Supplemental Figure VIB ). In response to H 2 O 2 , there was an increase in TRX1 association with the plasma membrane (*PϽ0.05 compared with tϭ0), as evidenced by cosedimentation with plasma membrane marker platelet EC adhesion molecule-1 (Supplemental Figure VIB 
TRX1 Translocation to the Plasma Membrane Is Dependent on TXNIP
The demonstration that TRX1 and TXNIP translocated to the membrane with similar time courses suggested that the translocation of TRX1 to the plasma membrane might be TXNIP dependent. To test this concept, we depleted TXNIP specifically with small interfering RNA (siRNA). In control siRNA-transfected cells, the amount of TRX1 associated with the membrane was significantly increased by H 2 O 2 stimulation (6.9-fold at 30 minutes) ( Figure 3A) . The association of TRX1 with the plasma membrane was significantly decreased by 85.9Ϯ4.3% in EC transfected with TXNIP siRNA ( Figure  3A) . Western analysis showed that TXNIP was depleted by 83.1Ϯ2.3% and that the inhibition of TRX1 association with the membrane was not the result of a reduction in total TRX1 expression (Supplemental Figure VII) .
The ability of TRX1 to interact with TXNIP occurs via the formation of a mixed disulfide requiring cysteine 247 of TXNIP. 8 Therefore, we tested the hypothesis that TXNIPdependent translocation to the plasma membrane involved an interaction between TXNIP and TRX1 by depleting TXNIP by siRNA and rescue with overexpression of TXNIP-Cys247Ser. In control siRNA-transfected EC, H 2 O 2 stimulated a dramatic 19-fold increase in TRX1 translocation to the plasma membrane in this series of experiments ( Figure 3B , 8Ϯ2 versus 151Ϯ11). In this experiment, depletion of TXNIP with siRNA caused a 90% decrease in TRX1 association with the plasma membrane ( Figure 3B, 16Ϯ3 versus 151Ϯ11) . Importantly, TXNIP depletion and rescue with TXNIP-Cys247Ser failed to restore H 2 O 2 -mediated TRX1 translocation to the plasma membrane ( Figure 3B ). In contrast, rescue with TXNIP-wild-type (WT) significantly restored TRX1 association with the plasma membrane compared with TXNIP-Cys247Ser (72Ϯ9 versus 16Ϯ3, Figure 3B ). The finding that TXNIP-Cys247Ser cannot restore TRX1 translocation indicates that a direct interaction for TXNIP with TRX1 via a disulfide linkage is necessary, as demonstrated previously by Patwari et al. 8 We further tested whether knockdown of TRX1 with siRNA had an effect on TXNIP translocation. Similar to previous experiments, unstimulated EC exhibited minimal plasma membrane-associated TXNIP (Supplemental Figure VIIIA and VIIIC) . TNF-␣ treatment for 30 minutes caused a dramatic increase in TXNIP translocation to the plasma membrane and was abolished in cells in which TRX1 was knocked down with siRNA. (Supplemental Figure VIIIB and VIIID) .
TXNIP-Cys247Ser failed to promote TRX1 translocation to the membrane, suggesting that formation by disulfide was critical for movement. Therefore, we analyzed the time course for TXNIP-TRX1 complex formation. Under basal conditions, there was little interaction of endogenous TRX1 with TXNIP-WT-GFP immunocomplexes ( Figure 3C, Tϭ0) , which is consistent with the demonstration that TXNIP-GFP was predominantly nuclear and that TRX1 was predominantly cytoplasmic (data not shown). In response to either H 2 O 2 or TNF-␣, TXNIP-TRX1 binding increased dramatically. Similar to the results from immunofluorescence and membrane sheet assay, TNF-␣ caused greater TXNIP translocation to the membrane than H 2 O 2 . 
TXNIP-TRX1 Promotes Tyrosine Phosphorylation of Plasma Membrane Proteins
We previously showed that H 2 O 2 stimulated tyrosine phosphorylation of membrane proteins in HUVEC. 24 Consistent with that finding, H 2 O 2 stimulated a time-dependent increase in plasma membrane tyrosine phosphorylation that was maximal at 30 minutes (8.3-fold, *PϽ0.05 compared with tϭ0, Figure 4A ). Depletion of either TXNIP or TRX1 with siRNA significantly inhibited protein tyrosine phosphorylation in response to H 2 O 2 at all time points ( Figure 4A , Supplemental Figure IXA to IXD). We also tested the ability of TXNIP to regulate the tyrosine phosphorylation of membrane-associated proteins in response to TNF-␣. In response to TNF-␣, phosphorylation increased with a time course similar to that of H 2 O 2 that was maximal at 30 minutes (18.5-fold, PϽ0.0005, Figure 4B ). Similar to results with H 2 O 2 , when either TXNIP or TRX1 was depleted with siRNA, there was significant inhibition of TNF-␣-stimulated membrane tyrosine phosphorylation ( Figure 4B ).
To evaluate the specific role of TRX1, we also depleted glutaredoxin-1 in HUVEC. In control siRNA-transfected cells, there was a 5.6-fold increase in tyrosine phosphorylation in response to H 2 O 2 at 30 minutes ( Figure 4C ). Interestingly, when glutaredoxin-1 was depleted, there was no change in membrane tyrosine phosphorylation, whereas there was a dramatic decrease after TRX1 depletion. Western blotting showed equivalent depletion of glutaredoxin-1 and TRX1 by specific siRNA (Supplemental Figure XA and XB) .
TXNIP-TRX1-Mediated Tyrosine Phosphorylation Is Redox Dependent
In accordance with the underlying hypothesis that TXNIP-TRX1 translocation and subsequent membrane protein tyrosine phosphorylation is redox dependent, we next investigated the effect of antioxidants. H 2 O 2 increased membrane protein tyrosine phosphorylation 3-fold above control ( Supplemental Figure XI) . Treatment of cells with the superoxide scavenger Tiron at 2 concentrations had no effect on 4G10 staining of EC membrane sheets under basal conditions. In contrast, pretreat-ment with Tiron before H 2 O 2 stimulation abolished membrane protein tyrosine phosphorylation (Supplemental Figure XI) .
TXNIP-TRX1 Regulates VEGFR2 Activation and Signaling
Because we previously showed that H 2 O 2 activated the VEGFR2, we hypothesized that the translocation of TXNIP and TRX1 might regulate VEGFR2 activation. 25 In control siRNA-transfected cells, H 2 O 2 stimulated a 4.5-fold increase in VEGFR2 tyrosine phosphorylation at 30 minutes (Supplemental Figure XIIA) . In contrast, in TXNIP siRNA-treated cells, there was only a 1.9-fold increase in VEGFR2 phosphorylation (Supplemental Figure XIIA) . Western blotting demonstrated that TXNIP siRNA did not alter expression of VEGFR2 or actin (Supplemental Figure XIIB) .
The role of VEGFR2 in plasma membrane tyrosine phosphorylation was investigated further using the specific inhibitor SU1498. There was no significant change in basal tyrosine phosphorylation compared with dimethyl sulfoxidetreated cells. However, after SU1498 treatment, plasma membrane tyrosine phosphorylation in response to H 2 O 2 for 30 minutes was almost completely inhibited ( Figure 4D ). Consistent with these findings, extracellular signal-regulated kinases-1/2 activation in response to H 2 O 2 was almost completely inhibited (Supplemental Figure XIIC) .
TRX1 Is Required to Promote Cell Migration
Early studies demonstrated that VEGF-mediated activation of VEGFR2, EC migration in vitro, and angiogenesis in vivo is dependent on the generation of endogenous H 2 O 2 . 26 More recently, the effects of VEGF on EC migration and tube formation were found to be dependent on extracellular signal-regulated kinases activation. 27 Because TXNIP-TRX1 was shown to be necessary for H 2 O 2 -mediated transactivation of VEGFR2 and subsequent extracellular signal-regulated kinases-1/2 activation, we investigated EC migration after scratch wound. EC migration after 16 hours under basal conditions was significant, with 40% recovery of the wound Figure 4 . Tyrosine phosphorylation of plasma membrane proteins requires TXNIP-TRX1, is specific for TRX1, and is mediated in part by VEGFR2. A and B, Quantification of 4G10 immunofluorescence of plasma membrane sheets prepared from HUVEC transfected with control (Con), TXNIP, or TRX1 siRNA and stimulated with 30 mol/L H 2 O 2 (A) or 10 ng/mL TNF-␣ (B). C, Quantification of 4G10 immunofluorescence of plasma membrane sheets prepared from HUVEC transfected with Con, glutaredoxin-1 (GRX), or TRX1 siRNA and stimulated with H 2 O 2 for 30 minutes. D, Quantification of 4G10-stained fluorescence of plasma membrane sheets prepared from EC pretreated with either dimethyl sulfoxide (DMSO) or the VEGFR2 inhibitor SU1498 before H 2 O 2 . nϭ5, *PϽ0.05 vs Con.
area. There was no difference in migration of EC transfected with either control or TRX1 siRNA (Figure 5A, 5E, and 5I ). However, when migration was stimulated by known EC agonists (VEGF, TNF-␣, or 30 mol/L H 2 O 2 ) for 16 hours, migration into the denuded area was markedly increased to 70% recovery ( Figure 5B to 5D and 5I). In contrast, agonistmediated EC migration was significantly decreased in cells transfected with TRX1 siRNA (Figure 5F to 5I).
TXNIP-TRX1 Interaction Is Required to Promote Cell Survival
Because VEGFR2 activation also promotes EC growth and survival, we next studied the effect of TXNIP on apoptosis induced by H 2 O 2 . HUVEC were transfected with control or TXNIP siRNA and allowed to recover for 48 hours, and then apoptosis was induced by treatment with 30 mol/L H 2 O 2 for 6 hours and 0% serum. Apoptosis measured by both terminal deoxynucleotidyl transferase dUTP nick-end labeling and nuclear fragmentation showed a significant increase when TXNIP was depleted. As measured by terminal deoxynucleotidyl transferase dUTP nick-end labeling, there was an increase from 3.9Ϯ2.3% to 28Ϯ4.7% (*PϽ0.05, Supplemental Figure XIIIA) , and by nuclear fragmentation, there was an increase from 8.7Ϯ0.6% to 22.9Ϯ0.8% (*PϽ0.05, Supplemental Figure  XIIIB) . A similar result was obtained using TNF-␣ (Supplemental Figure XIV) .
To show that the mechanism by which TXNIP protected EC from apoptosis required formation of a TXNIP-TRX1 complex, we performed rescue experiments analogous to those shown in Figure 3 . In cells rescued with TXNIP-WT, apoptosis in response to 30 mol/L H 2 O 2 for 6 hours was 7.6Ϯ0.8% ( Figure  6A ). This was not significantly different from cells exposed to vehicle (5.1Ϯ0.5%, PϾ0.05). In contrast, cells rescued with TXNIP-Cys247Ser exhibited a significant increase in apoptosis to 21.5Ϯ0.9%, compared with cells rescued with TXNIP-Cys247Ser and treated with vehicle (8.9Ϯ0.9, *PϽ0.0005). The level of TXNIP-WT and TXNIP-Cys247Ser expression did not differ significantly as analyzed by Western blotting ( Figure 6B ). These data demonstrate that the ability of TXNIP to promote cell survival after exposure to H 2 O 2 is dependent on its interaction with TRX1.
Discussion
The major finding of this study is that the TXNIP-TRX1 complex acts as a redox-sensitive mediator to control VEGFR2 signaling, thereby promoting cell survival under oxidative stress. We describe 2 novel functions for TXNIP. First, the present study suggests a positive regulatory role for TXNIP in endothelial function when it combines with TRX1 to form a complex. Previously the TXNIP-TRX1 complex was thought to mediate solely inhibition of TRX1 function. 6 Second, the translocation of TXNIP to the plasma membrane represents further evidence that TXNIP is an important mediator of signaling that is subcellular specific, as shown by its previously described roles in the nucleus and mitochondria. 28, 29 Mechanistically, we propose (Supplemental Figure  XV) that a physiologically relevant level of ROS (10 ng/mL TNF-␣ or 30 mol/L H 2 O 2 ) promotes an interaction between TXNIP and TRX1 via a mixed disulfide (Cys247 of TXNIP and Cys35 of TRX1) that promotes TXNIP movement from the nucleus. 8 Subsequently, the TXNIP-TRX1 complex translocates to the plasma membrane, where it mediates VEGFR2 activation. VEGFR2 activation stimulates downstream signal transduction that promotes EC survival. In addition, we showed that EC migration in response to VEGF, TNF, and H 2 O 2 was dependent on a TXNIP-TRX1 complex. These data support an important role for TXNIP as an intracellular scaffold that regulates plasma membrane localized signal transduction in response to oxidative stress. Furthermore, we propose that a functional consequence of TXNIP-TRX1 membrane translocation increases EC survival under oxidative stress, thereby enabling expression of proinflammatory mediators, such as vascular cell adhesion molecule-1 and IL1.
The finding that TXNIP mediates translocation of TRX1 to the plasma membrane is consistent with previous reports that TXNIP is a member of the ␣-arrestin family acting as an intracellular scaffold. 30 Specifically, several studies showed in yeast that the arrestin-related trafficking adaptors (ARTs), to which ␣-arrestin members are related, play a critical role in cargo transport of amino acid transporters. [31] [32] [33] We propose that TXNIP translocates to the plasma membrane in response to TNF and H 2 O 2 via a mechanism similar to that described for ARTs in yeast. Both ARTs and ␣-arrestins possess PPxY motifs that facilitate an interaction with E3 ubiquitin ligases. This complex was found to translocate to the plasma membrane, where it ubiquitinates membrane-associated transporters. 31 Sequence analysis of TXNIP reveals 2 evolutionarily conserved PPxY motifs within its carboxyl terminus, which we have shown are required for the translocation of TXNIP from the nucleus to the plasma membrane (C. World, PhD, and B.C. Berk, MD, PhD, unpublished data, 2010).
It is likely that the TXNIP-TRX1 complex promotes VEGFR2 activation and plasma membrane protein tyrosine phosphorylation in response to ROS by several mechanisms. First, binding of TXNIP-TRX1 to VEGFR2 may promote receptor dimerization and autoactivation. Second, Src activity is regulated by changes in its localization via an interaction with ␤-arrestin1. 34, 35 This was found to require 2 SH3binding domains found within the N terminus of ␤-arrestin1, which are also present in TXNIP. 35 Third, TRX1 has been shown to modulate the redox state and function of tyrosine phosphatases such as Src homology 2-containing tyrosine phosphatase. 3, 4 Interestingly, Src homology 2-containing tyrosine phosphatase regulates the interaction of RasGAP with VEGFR2, 36 suggesting cross-talk of the Ras pathway described above. 37 Finally, there may be other proteins bound to the TXNIP-TRX1 complex that facilitate VEGFR2 activation.
Previously, it was shown that local generation of low levels of H 2 O 2 (10 to 50 mol/L) is essential for growth factor receptor signaling. 38 For example, peroxiredoxin I and II association with the platelet-derived growth factor receptor in vascular smooth muscle cells regulated platelet-derived growth factor-dependent signaling and cell migration. 39 Very recently, it was found that plasma membrane-associated peroxiredoxin I activity was preferentially inhibited after phosphorylation by c-Src, resulting in the localized accumulation of H 2 O 2 and enhanced platelet-derived growth factor receptor signaling. 40 We propose that oxidation of TRX1 and interaction with TXNIP at low levels of ROS (10 to 50 mol/L) is another mediator of localized signaling.
The present findings suggest a novel role for TXNIP in vascular pathophysiology. Previously, TXNIP had an established role in the inflammatory response mediated by a 2-component mechanism. First, TXNIP expression in EC is low but highly induced in EC exposed to disturbed flow, inflammatory cytokines, and hyperglycemia. [41] [42] [43] Second, TXNIP binding to TRX1 relieves inhibition of ASK1 enabling c-Jun N-terminal kinase-dependent induction of vascular cell adhesion molecule-1. 13 In addition, previous studies that used a high concentration of ROS indicated TXNIP was proapoptotic via activation of multiple death pathways. 44 However, the current data show that in response to physiological levels of ROS, TXNIP is actually prosurvival. This prosurvival effect may actually be proinflammatory because it enables EC to live long enough to express adhesion molecules and cytokines necessary for chronic inflammation, such as that found with atherosclerosis. Figure 6 . TXNIP promotes cell survival that requires TXNIP-TRX1 binding. A, Apoptosis assayed by nuclear morphology of EC transfected with TXNIP siRNA, rescued with either TXNIP-WT-GFP or TXNIP-Cys247Ser-GFP, and treated with H 2 O 2 for 6 hours. *PϽ0.05 vs TXNIP siRNA rescued with TXNIP-WT-GFP. B, Western analysis of endogenous TXNIP and TXNIP-GFP. Note that the molecular mass of TXNIP is Ϸ48 kDa, and that of TXNIP-GFP is Ϸ75 kDa.
